vinpocetine: Clinical Trials

6 trials of vinpocetine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 not yet recruiting, 1 recruiting, 1 suspended. 4 Phase 2, 3 Phase 3, 2 Phase 1, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 24Completed 1, Recruiting 1, Suspended 1, Unknown 1
Phase 33Completed 1, Recruiting 1, Unknown 1
Phase 12Not yet recruiting 1, Suspended 1
Not applicable1Completed 1

Follow vinpocetine: new trials by email Literature Review of vinpocetine trials Research Report on vinpocetine

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Vinpocetine in Patients With Parkinsonian Disease
Levodopa Carbidopa, Vinpocetine - Parkinson Disease
Phase 2 / Phase 3RecruitingTanta University602025-11-102025-12-10
Dose Escalation Study of Vinpocetine in Healthy Volunteers
Vinpocetine - Fetal Alcohol Spectrum Disorders
Phase 1Not yet recruitingStanford University202025-06-012024-10-10
Clinical Outcome of Vinpocetine in Diabetic Nephropathy
Vinpocetine, Standard Therapy, Placebo - Diabetic Kidney Disease, Diabetic Nephropathies
Phase 2 / Phase 3UnknownAin Shams University642024-07-102024-07-11
Vinpocetine Inhibits NF-κB-dependent Inflammation in Acute Ischemic Stroke Patients
vinpocetine, Aspirin - Stroke, Immunoregulation
Phase 2 / Phase 3CompletedTianjin Medical University General Hospital602014-05-012016-08-25
Cognitive Effects of Vinpocetine in Healthy Adults and Patients With Epilepsy
Vinpocetine - Epilepsy
Phase 1 / Phase 2SuspendedStanford University302012-02-012024-08-16
Single Photon Emission Computed Tomography (SPECT) Imaging Study of Professional American Football Players
Multivitamin Supplement intervention - Traumatic Brain Injury
Not applicableCompletedAmen Clinics, Inc.1002009-05-012012-01-24

Conditions studied

Brain Injuries, Traumatic (1)  ·  Diabetic Nephropathies (1)  ·  Epilepsy (1)  ·  Fetal Alcohol Spectrum Disorders (1)  ·  Inflammation (1)  ·  Parkinson Disease (1)  ·  Stroke (1)

Sponsors

Stanford University (2)  ·  Ain Shams University (1)  ·  Amen Clinics, Inc. (1)  ·  Tanta University (1)  ·  Tianjin Medical University General Hospital (1)

Countries

Egypt (2)  ·  United States (2)

Top investigators

Daniel G Amen, MD (1)  ·  Kimford J Meador, MD (1)

Results publications

PMID 21304145, PMID 21615001, PMID 28691141

NIH funding

R61AA031291 (1)